stocks
Worldwide NFT Inc. (OTCMKTS: WNFT) Bulls Accumulating at Current Levels After Massive 76% Drop on WC Appeal
Published
2 years agoon
By
Boe Rimes![](https://microcapdaily.com/wp-content/uploads/2022/06/FOJA9toz_400x400.jpg)
Worldwide NFT Inc. (OTCMKTS: WNFT) saw a massive drop of 76% on Friday after the Company filed an 8k stating Warwick Calasse, the Company’s former CEO has appealed the lower court’s rulings regarding the cancellation of shares and it is unlikely that the company can enter into any acquisition or reverse merger agreement during the course of this litigation. This is a big blow to the WNFT formerly Goff Corp (OTCMKTS: GOFF) shareholders who were looking for something to happen right away with this GS rm play. The shorts got aggressive on Friday and decimated the share price to a low of $0.054 on the day closing over $0.06 where the stock has formed a new base on just under $3 million in dollar volume for the day. WNFT is likely to be under heavy accumulation in the coming days; this is after all a George Sharp ticker and everyone remembers the legendary summer of George when TSNP/HMBL and also forwardly skyrocketed.
WNFT is the new ticker for GOFF, a David Lazar SPAC that was taken over by RM stock whizz George Sharp who was awarded Custodianship. Since than Mr. Sharp has been awarded CEO and the majority voting block of stock recently winning two judgements against Mr. Warwick Calasse who is now appealing. While the company is confident that the rulings will be upheld, it is unlikely that the company can enter into any acquisition or reverse merger agreement during the course of this litigation. As such, no such transactions can be deemed to be pending. With the completion of the company’s name change and forward split, WNFT is now awaiting the conclusion of the court proceedings with former officer, Warwick Calasse.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Worldwide NFT Inc. (OTCMKTS: WNFT) is the new name and ticker for Goff Corp (OTCMKTS: GOFF) currently operating out of New York, NY is a clean shell with 0 debt and a perfect merger candidate that was a David Lazar SPAC before George Sharp was awarded Custodianship. The Company was incorporated in the State of Nevada on July 12, 2010 and operated as an exploration stage mining company, that engaged in exploration and mining of mineral properties. They focused on gold and silver production. Since 2013, the Company has been dormant 2021. Since custodianship was awarded to Mr. Sharp, all liabilities other than George Sharp’s judgement have been discharged by the Nevada District Court, Clark County.
On May 26, 2021, George Sharp was appointed as custodian for the registrant, Goff Corp., by Order Granting Motion to (1) Intervene, (2) Remove Custodian, (3) Appoint George Sharp as Custodian, and (4) for Temporary Restraining Order and Preliminary Injunction on Order Shortening Time, Case No A-20-815182-B, Dept. No. XVI issued by the District Court of the State of Nevada in and for Clark County (the “Court Order”). Under his authority as Custodian George Sharp appointed himself as the sole member of the Board and President, Secretary and Treasurer of the Company by resolutions of the registrant’s Board of Directors on May 26, 2021.
Mr. George Sharp is an experienced businessman with a diverse background in information technology and growth companies. After studying at Canada’s University of Waterloo, George joined the Engineering Department of the City of Calgary’s Electric System. There, George engineered a software application to more accurately examine the physical stresses on electrical wood poles. That effort garnered him recognition at the 1983 Stanford University Congress of Electrical Engineers. George was then recruited to join Northern Telecom in Bramalea, Ontario as a software engineering consultant. In the early 1990s, George founded Progressive Microsystem Designs to develop a series of business software applications for the emerging microcomputer market. The centerpiece of PMD was one of the first Human Resources Administration software products designed for microcomputers. Eventually, George relocated PMD to Southern California in order to better service the bulk of its clients. A former consultant to OTC Markets Group, George now provides services to publicly traded small companies seeking management advice; routes, including financing, towards progress; and, looking to stay onside of regulations.
Microcapdaily was among the first to report on George Sharps TSNP on November 15, 2020 when the stock was trading around $0.003 just as it was beginning its historic rise to multi-dollars and the reverse merge into HMBL. We stated at the time: “TSNP is a clean shell operating out of Oklahoma City, Oklahoma. The Company recently announced it has entered into an agreement with HUMBL, LLC to merge the two entities. In an all-stock transaction, the members of HUMBL will receive preferred shares of Tesoro in exchange for their HUMBL holdings.”
WNFT has an ambitious vision to become the first publicly traded NFT Company; according to a January 2021 report from Business Insider NFTs ballooned to a $41 billion market in 2021 and are catching up to the total size of the global fine art market. Currently there are around 28.6 million wallets trading NFTs as of December 2021. China is the country with the biggest interest in NFT opportunities. OpenSea as the largest peer-to-peer marketplace for NFTs, with a total trade volume of around $6.5 billion. The company has also helped to launch the rise of range of other competitors, like Axie Infinity, which trades around $2.1 billion at present.
In recent years there have been a number of hugely successful David Lazar custodianship/SPAC RM deals that have even spawned the message board; David Lazar, OTC SPAC’s/CUSTODIAN Plays on Investorshub.com. Investor Sentiment in GOFF is high.
To Find out the inside Scoop on WNFT Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
On Friday the stock dropped 76% after the Company filed an 8k stating “Warwick Calasse, the Company’s former CEO has appealed the lower court’s rulings regarding the cancellation of shares, previously issued to him, to the Nevada Supreme Court. While the company is confident that the rulings will be upheld, it is unlikely that the company can enter into any acquisition or reverse merger agreement during the course of this litigation. As such, no such transactions can be deemed to be pending. With the completion of the company’s name change and forward split, WNFT is now awaiting the conclusion of the court proceedings with former officer, Warwick Calasse.
WNFT reminds shareholders and prospective investors to rely only on the company’s statements and NOT the musings of unrelated parties regarding any transaction or other company event.
WNFT has entered into an agreement with Forwardly, Inc. (OTCMKT: FORW), whereby Forwardly will purchase an WNFT warrant providing the right to purchase 5 million WNFT warrant shares at $.32 per warrant share. The warrant must be exercised either in full or in part within two years of issuance. Forwardly will pay WNFT $200,000 for this warrant. Mr. Sharp is the CEO of both WNFT and Forwardly.
WNFT is in the process of negotiating up to $5 million in equity financing to be used as operational capital by successful acquisition or reverse merger targets.
Forwardly is an opportunity investor seeking to partner in fresh ideas. The company is headed by George Sharp, a longtime whistleblower, advocate against microcap fraud, and defender of shareholder rights. In addition to his continued participation in these activities, Mr. Sharp consults to public companies, attorneys and those associated with the financial markets. He is also a former consultant to OTC Markets Group, Inc.
$WNFT
Worldwide NFT Inc.
Pink Current Information
Outstanding Shares
178,250,000
06/29/2022 pic.twitter.com/aepgScFdW7— Randylus (@randylus) June 29, 2022
For more on WNFT Subscribe Right Now!
Currently trading at a $32 million market valuation WNFT is a debt free fully reporting reverse merger play from stock whizz George Sharp known for taking TSNP / HMBL from well under a penny to over $6 per share. On June 29 GOFF affected the name and ticker change and became Worldwide NFT Inc. (OTCMKTS: WNFT). The stock saw a massive drop of 76% on Friday after the Company filed an 8k stating Warwick Calasse, the Company’s former CEO has appealed the lower court’s rulings regarding the cancellation of shares and it is unlikely that the company can enter into any acquisition or reverse merger agreement during the course of this litigation. This is a big blow to the WNFT shareholders who were looking for something to happen right away with this GS rm play. From here WNFT should recover some, the stock was significant oversold on Friday and the Company is the same Company with the same significant potential that GOFF always had with stock whizz George Sharp behind it, it’s only a matter of time before good things start happening here. We will be updating on WNFT when more details emerge so make sure you are subscribed to Microcapdaily so you dont miss it.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in WNFT either long or short and we have not been compensated for this article
You may like
Featured
Clean Vision Corp (OTC: CLNV): Overcoming the Plastic Waste Crisis
Published
8 months agoon
January 18, 2024![](https://microcapdaily.com/wp-content/uploads/2024/01/the-bottle-5128607_1280.jpg)
Clean Vision Corporation (OTC: CLNV) has experienced several interesting developments recently, but it hasn’t noticeably influenced the market with any substantial gains. Nonetheless, we believe it’s worth providing an update on the company given it’s been a few months since our last mention. In today’s discussion, we’ll explore a variety of updates and their significance, with aim of providing insight on what to expect for 2024.
Background:
Clean Vision is led by Dan Bates, and their goal is to tackle the global plastic waste crisis head-on. Their wholly owned subsidiary, Clean Seas, has developed the Plastic Conversion Network (PCN), a groundbreaking technology aimed at diverting millions of tons of waste plastic from landfills, incineration, and oceans. The PCN converts this plastic feedstock into clean fuels and green hydrogen, significantly reducing reliance on fossil fuels and lowering the carbon footprint.
For a brief 2 minute overview on the company, feel free to reference the video CLNV’s subsidiary put together on YouTube. Here’s the link.
Clean Seas utilizes proven pyrolysis technology to produce environmentally friendly products, which are sold to multinational petrochemical companies, driving the circular plastic economy. Operational PCN facilities are already in place in Morocco and India, with additional conversion facilities in development across West Virginia, Arizona, and Southeast Asia. Long-term feedstock supply agreements exceeding one million tons of waste plastic annually have been secured at no cost.
Their recently trademarked brand, AquaH®, is produced in their PCN. According to the release, it offers a differentiated green hydrogen product from carbon-neutral sources. Currently, hydrogen is predominantly produced through methods that involve fossil fuels, which of course contributes to global carbon emissions. Furthermore according to Deloitte’s 2023 global green hydrogen outlook, this could be a $1.4T annual market by 2050.
$65 Million Plastic Conversion Facility:
CLNV is making big moves in West Virginia and according to the release on October 24th, 2023, they’ve brought in some serious players—CDI Engineering Solutions and ERM—to help out with their Clean-Seas West Virginia project.
CDI has over 70 years of experience integrating engineering, design, project support, procurement and construction management services to the energy, chemicals and electrical infrastructure markets.
ERM is the world’s largest advisory firm focused solely on sustainability, offering environmental, health, safety, risk and social expertise for more than 50 years with more than 8,500 dedicated professionals operating across 40 countries.
The plan is to kick things off in 2024, turning 100 tons of plastic every day into recycled plastics and clean fuels. It’s a hefty project with a $65 million investment, creating over 200 jobs initially. And they’re not stopping there—they want to scale up to 500 tons of plastic per day over time.
West Virginia Governor Jim Justice is also on board, throwing over $12 million in state incentives to support the project.
Governor Jim Justice made a reference to Clean Seas in his state of the union address. If you want to catch the mention, go to 34:15 in the video. The three minutes leading up to it are also worth reviewing.
Subscribe to Microcapdaily.com Right Now by entering your Email in the box below.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Launches Global Operations:
CLNV made another significant advancement, planning to launch waste plastic conversion facilities in the European Union, Eastern Europe, and Southeast Asia. This will be accomplished through their new subsidiary, Clean-Seas Partners UK Limited (CS-UK), who of course shares the same vision of creating sustainable solutions to the global plastic pollution crisis.
Under the leadership of Managing Director Shaun Wootton, CS-UK will play a crucial role in strategic project development and investment facilitation, leveraging established relationships in the Middle East, Southeast Asia, and Europe.
To fortify effective governance and strategic direction, CS-UK is assembling a distinguished board with internationally recognized figures in banking, sustainability, and energy. This approach aims to have a diverse and experienced board guiding CS-UK in realizing its vision of promoting sustainability and environmental stewardship across diverse regions.
$340 Million Bond Offering:
CLNV even announced they partnered with a global advisory firm, Grant Thornton, to issue up to $340 million in Green Bonds. This is the world’s sixth-largest network of independent accounting and consulting firms, employing 62,000 people in more than 130 countries and had revenues of $6.6 billion in 2021. These bonds will fund the expansion of Clean Vision’s Plastic Conversion Network (PCN) under the “Clean-Seas” initiative worldwide, aimed at combatting plastic pollution on a global scale.
With the Green Bond’s net proceeds, CLNV plans to deploy at least six plastic waste conversion lines globally, with strategic locations in West Virginia, Arizona, Southeast Asia, and expansion in Morocco. The Green Bond is also expected to attract environmentally conscious investors, setting a new standard for corporate responsibility.
$15M Government Loan:
Lastly, under the capable management of Huntington Bank, CLNV has recently secured a $15 million government loan. What sets this apart is that the loan is FORGIVABLE.
A forgivable loan is a type of loan where the borrower is not required to repay the borrowed amount under certain conditions. Typically, these conditions are related to the borrower meeting specific criteria, such as using the funds for approved purposes, maintaining certain employment levels, or achieving predetermined goals. If the borrower fulfills these conditions, the loan is forgiven, and they are not obligated to repay the borrowed amount. Forgivable loans are often used as an incentive or support for specific activities, such as job creation, small business development, or other initiatives that contribute to economic growth or community welfare.
Not to mention it won’t result in any dilution for shareholders. This is an unexpected and uncommon accomplishment for an OTC company. Securing a government loan of this size without any dilution is truly impressive.
Conclusion:
CLNV has made impressive strides tackling the global plastic waste crisis, especially given their valuation of merely $22.65 million. The team has swiftly achieved key objectives, including a $65 million plastic conversion facility in West Virginia, global expansion through Clean-Seas Partners UK Limited, a $340 million Green Bond Offering, and a remarkable $15 million forgivable government loan. The vast $1.4 trillion market they’re tapping into offers an interesting opportunity with current indicators looking positive. Nevertheless, it’s crucial to acknowledge that there is still significant work ahead, and the team needs to maintain consistent execution to turn this potential into a reality.
We will update you on CLNV when more details emerge, subscribe to Microcapdaily to follow along!
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: We have not been compensated for this article/video. MicroCap Daily is not an investment advisor; this article/video does not provide investment advice. Always do your research, make your own investment decisions, or consult with your nearest financial advisor. This article/video is not a solicitation or recommendation to buy, sell, or hold securities. This article/video is our opinion, is meant for informational and educational purposes only, and does not provide investment advice. Past performance is not indicative of future performance.
Picture by pasja1000 from Pixabay
BioPharma
Bioxytran (OTCMKTS: BIXT) Peer-Review Published Showing Functional Cure for COVID-19
Published
1 year agoon
March 28, 2023By
Chris Meeks![](https://microcapdaily.com/wp-content/uploads/2023/03/DisintegratingCOVID.png)
On the cusp of a cure for COVID, one of the most promising yet under-the-radar biotech stocks on the OTC is generating much well-deserved buzz in the scientific community and is poised to go viral.
Bioxytran Inc. (OTCMKTS: BIXT) over the weekend had their phase 2 top-line results published in the peer-reviewed journal “Vaccines.” There is a not-so-subtle tinge of irony in that name because while their drug is nothing like a vaccine, there is no doubt about its efficacy– 100% PCR negative rate by day 7 versus 6% in placebo. The medical journal article was titled “An Oral Galectin Inhibitor in COVID-19 – A Phase 2 Randomized Controlled Trial.” This is a landmark journal article because – until now – only one other drug, Harvoni, had equaled a 100% responders rate in the past decade. Harvoni ultimately ended up being a cure for Hepatitis C Virus.
At this point in Bioxytran’s drug development pipeline, it essentially has a functional cure for COVID-19 that simply needs a pivotal phase 3 trial to show the true extent of their discovery. Their drug is a galectin antagonist, which neutralizes the now infamous spike proteins by placing a carbohydrate sheath over the spikes making attachment to the cell impossible. The carbohydrates binding grip is so tight on the virus that it carries it around in the blood until it is eventually filtered out by the liver and excreted.
If solving the pandemic wasn’t enough, the company recently reported that in vitro studies suggest the drug would be effective in Influenza and RSV. Yet despite the fact that this one drug could seemingly end upper respiratory infections, which most of us refer to as a “common cold,” it has a nominal market cap of just $50 million.
For the past three months, BIXT has been teasing this peer-reviewed article as a catalyst and a major value inflection point for the company. Despite that, investors haven’t gotten the hint, and have been steadily selling into this inflection point. Even though the company has yet to report it in a press release, the scientific community is understandably going crazy over it. Investors, however, are seemingly oblivious to the viral traffic and simply not paying attention to the sheer magnitude of the discovery–a functional cure for COVID and the methodology to seemingly combat any virus.
One of the reasons peer review is so important for a biotech is that major media outlets won’t touch the science without it. With its publication, this article means that BIXT now has an opportunity to tell its story on network media. The biggest risk that investors now face in BIXT is FOMO, driven by an unexpected media appearance that ushers unbridled buying into the name and leaves tepid investors chasing up.
If the article itself wasn’t enough, their peer-reviewed article was picked up by a major biotech influencer on Twitter, quickly garnering more than 100k hits. The influencer, Chris Turnbull, summarized the article highlighting key points like the rapid viral clearance in 3 days through entry inhibition and suggested the ideal use is when you know you were exposed. He hammered the point that ProLectin-M was for standard-risk patients and that Paxlovid was for high-risk groups with at least one medical condition.
This discovery changes the COVID landscape permanently. Multi-billion dollar antiviral drugs like Paxlovid and Lagevrio can’t hold a candle to the viral clearing power of BIXT’s galectin antagonist. Looking at the Twitter account of BIXT Chief Commercial Officer Michael Sheikh, it’s clear that there are some ongoing discussions with big pharma that have not yielded any fruit. But big pharma may not be their only option. BIXT has also said they are looking to partner with companies with large cash balance sheets. Both galectin antagonist companies Galectin Therapeutics (NASDAQ: GALT) and Galecto Bioscience (NASDAQ: GLTO) fit the profile and are the subject of a number of relatively supportive tweets by Sheikh. Sleuthing Sheikh’s LinkedIn profile reveals hardcore evidence of that sort of dealmaking with clusters of top executives in certain companies and networking, which suggests significant activity among their larger Galectin-focused peers. In an emerging growth interview, the CCO did say that he got a lot of business cards and was networking.
There exists a huge chasm between the current market cap and what it ought to be given that it successfully completed a phase 2 and nailed the endpoint with a perfect score. The CCO described in an Emerging Growth video how valuations work and a number of comparables in the $500 million range for a number of disease indications that BIXT is developing. The stock has a very tiny float of 19 million with an OS of 123 million. This represents a float of 15% and insiders own over 60%. There is no dilution from the convertible notes as they have company-friendly terms that allow up to 5% conversion into restricted common stock. In an Emerging Growth interview a couple of months ago, the CCO acknowledged the stock’s current challenge, indicating a legacy seller was responsible for half the daily volume and was almost gone. In early March after a ZeroHedge article was published, the stock went on a record run to $1.05 in a matter of minutes before short forces brought it back down. On March 7th it looks like the seller ran out of inventory for the day and the demand just lifted the stock price allowing it to go through a short period of natural price discovery. The long-term legacy seller seems to be at the end of his block, which means any news announcement could push the stock higher.
Low-Risk Explosive Reward Profile
There is no doubt that BIXT has incredible potential yet the stock continues to languish. With the anemic volume, it’s very difficult to diagnose what the root cause is for the disconnect from the comparable valuations established by big pharma in the $500 million region and BIXT’s current $50M cap. If one article that generated a little bit of buying pushed it to the brink of explosiveness, perhaps there is more stock from this legacy seller that is still controlling the narrative.
Upcoming Catalysts
For the investor with a longer-term view, BIXT represents a safe place to park funds for explosive returns. The upcoming catalysts are a dosing of patients in India for the dose optimization trial, a potential IND from the FDA, and of course, the announcement of the peer-reviewed journal article. While it’s uncertain which catalyst will send the stock into overdrive it’s abundantly clear this is one of the most undervalued stocks in OTC.
Pound-for-Pound Comparison of Paxlovid and PLM
Paxlovid also helped lower the length of time people with underlying medical conditions were infectious. However, Paxlovid is not a very effective drug and is walking a tightrope with respect to its approval as more and more real-world data reveals their toxicity.
Here is a chart capture from the company’s latest scientific webinar that shows a side-by-side comparison for illustrative purposes. The charts show that Paxlovid can barely turn 30% of the patients PCR negative by day 20 whereas a majority of the PLM patients were PCR negative on day 3. This is an absolute game-changer in controlling the pandemic. The other thing that this peer-reviewed journal highlighted is that the symptoms were eliminated and without those symptoms, people were unlikely to develop Long COVID. It’s very reasonable to believe that PLM stops Long COVID due to its mechanism of action as well as the fact that it appeared to eliminate symptoms in this trial, as seen in the picture below. While it’s nice that Paxlovid stops hospitalization and death, PLM takes it to a new level by making you feel better faster and eliminating the risk of Long COVID.
Investment Summary
Bioxytran is not only sitting on a solution for COVID and a possible end to the pandemic, but it appears they can also treat Long COVID and a number of viruses. All this information is out there in the public domain and investors seem to be sitting on their hands waiting for something more to happen. It’s unclear what that trigger will be. Will it be a video interview on major media? Will it be the IND announcement from the FDA? Or will it be an explosion of XBB1.16 cases in India whereby they fast-track the PLM development in the country? Whatever the catalyst, the risk/ reward scenario on BIXT is one of the best in all of the OTC. The small float coupled with the lack of an S-1 on file eliminating the risk of immediate dilution bodes well for either a long-term or medium-term investor.
Investors need to ask themselves if they could have invested in penicillin knowing the impact it was going to have last century would they have dived in? Investors are facing a similar scenario with PLM. This is perhaps the biggest antiviral discovery of the century which amounts to a functional cure for COVID and possibly other viruses. Will investors stay on the sideline because some grumpy shareholder is selling not allowing immediate price discovery or will they step up to secure their place in history? Time will tell, but what is certain is that PLM will save an immeasurable amount of lives and take away untold suffering if it can navigate its way to regulatory approval. But while BIXT may be curing Covid, there is still only one cure for FOMO. Investors would do well to stop waiting on the sidelines to enter or affirm their positions before this game-changing anti-viral goes viral.
Disclosure: MicroCap Daily and its owners do not have a position in the stocks posted and have posted this article for free without editorial input. This article was written by a guest contributor and solely reflects his opinions.
stocks
Frontera Group Inc (OTCMKTS: FRTG) Breakout as Co Commences Commercial Sales of Immersient Following IntelliMedia Networks IP Acquisition
Published
2 years agoon
August 26, 2022By
Boe Rimes![](https://microcapdaily.com/wp-content/uploads/2022/08/e503cd60-20d1-4676-9528-485ad9a5abb2-1.png)
Frontera Group Inc (OTCMKTS: FRTG) is making an explosive move northbound in recent trading and is currently under heavy accumulation but still unnoticed by most investors. This is changing quickly as some heavy hitters have jumped on FRTG. The Company is only trading for a $2.7 total valuation with a float of just 3,280,000 FRTG is an SEC filer looking to uplist to OTCQB with a 10k coming out any day. From current levels FRTG has a lot of room to grow. Recently Frontera signed a marketing agreement with Long Side Ventures LLC, following an earlier marketing agreement with Stephen Steen on April 27, 2022.
Earlier this year FRTG acquired intellectual property rights from Intellimiedia Networks, Inc., for $5 million in cash and 20 million shares of FRTG. According to the 8k FRTG plans to raise $12 million by year end 2023. Essentially, Intellimedia turned over its assets and Intellectual Properties to Frontera, as Frontera has the platform in place to maximize the value of the purchased IP. Intellimedia Networks is a US and India-based technology company that designs and deploys cloud platforms and applications that create immersive experiences. Intellimedia’s award-winning products utilize AR, VR, and AI to enhance media, training, education, virtual event broadcasting, real estate, and other applications. Frontera brought on business execs Teodros Gessesse and Darshan Sedani.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Frontera Group Inc (OTCMKTS: FRTG) is a strategic acquirer of intellectual property and revenue-generating companies in the technology and human capital markets. It is developing and executing an aggressive, four-tier acquisition and implementation strategy intended to provide substantial increases in profitability to its acquisitions in industries which possess traditionally low and stagnant EBITDA multiples. The Company has identified and is currently pursuing several revenue-generating acquisition targets.
Earlier this year FRTG acquired intellectual property rights from Intellimiedia Networks, Inc., for $5 million in cash and 20 million shares of FRTG. According to the 8k FRTG plans to raise $12 million by year end 2023. Essentially, Intellimedia turned over its assets and Intellectual Properties to Frontera, as Frontera has the platform in place to maximize the value of the purchased IP. Intellimedia Networks is a US and India-based technology company that designs and deploys cloud platforms and applications that create immersive experiences. Intellimedia’s award-winning products utilize AR, VR, and AI to enhance media, training, education, virtual event broadcasting, real estate, and other applications.
In connection with the acquisition Teodros Gessesse was appointed as the Chief Marketing Officer of the Company. Mr. Gessesse’s initial annual base salary will be $150,000. Mr. Gessesse will be eligible to receive a quarterly bonus as determined by, and within the sole discretion of, the BOD and was granted 23,500,000 shares of FRTG. Also, Darshan Sedani was appointed as the Chief Visionary Officer of the Company. Mr. Sedani’s initial annual base salary will be $150,000. Mr. Sedani will be eligible to receive a quarterly bonus as determined by, and within the sole discretion of, the BOD and was granted 31,500,000 shares of FRTG. The deal closed on August 17.
$FRTG Our primary objective: To deliver substantial increases in profitability to our acquisitions in mature industries which possess traditionally low and stagnant EBITDA multiples. pic.twitter.com/eTZ6MoHOmE
— FRTGtech (@FRTGtech) August 26, 2022
To Find out the inside Scoop on FRTG Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
In June FRTG released the 3.0 version of its Mixie Holoport immersive reality framework with Extended Reality (XR) support (“Mixie Holoport XR”). Mixie Holoport XR is a National Association of Broadcasters (NAB) Product of the Year award winner, setting the benchmark for immersive realism in Augmented Reality (AR), Mixed Reality (MR), and Virtual Reality (VR) applications. Frontera recently acquired the Mixie Holoport IP to enhance Metaverse business applications.
Frontera also launched its Mixie AI 2.0 powered live video broadcasting solution that will be targeting automated broadcasting applications. Frontera’s recent acquisition of Intellimedia’s Mixie suite of solutions has provided Frontera with a cutting-edge mix of media technology, learning and training platforms, and event broadcasting technologies that position the company at the technology forefront of a new wave of immersive and engaging technologies that continue to redefine applications. Intellimedia’s Mixie AI 2.0 solutions were utilized for Cricket AI Tata Open Tournament and the ISSF Shooting World Championship to simplify and automate the capture, analysis, discovery, and broadcast of both events. The resulting professional broadcast quality and dramatic cost reduction have become a wake-up call for both organizations to stage and broadcast future events.
Earlier this month FRTG reported it has commenced commercial sales and marketing efforts of Immersient, the intellectual property which was acquired from IntelliMedia Networks, Inc. and formerly sold under the Mixie brand name. Now sold and marketed under the Immersient brand, Frontera’s cloud media platform connects content producers, educational institutions, and event producers with participants and viewers, delivering immersive, personal experiences, interactive participation, existing device compatibility, familiar user conventions, and reliable, “always available” service. The Immersient cloud media platform allows its clients to focus on their core businesses, knowing their end users are enjoying state-of-the-art experiences. With its frictionless device and network independent approach to immersive virtual, augmented, and mixed reality environments, Immersient delivers next-generation group collaboration and communications, interactive distance learning and training, and virtualized events, meetings, expos, conferences, and trade shows.
$FRTG ⛱ pic.twitter.com/dHoX6B1NCG
— Mako Warren (@mako_warren) August 26, 2022
For More on FRTG Subscribe Right Now!
Currently trading at a $2,7 million market valuation FRTG has 55,563,482 shares outstanding and just 3,280,000 shares in the float. The Company has a clean balance sheet and recently filed a 10Q with a 10k on the way and looking to uplist to OTCQB. FRTG is an exciting story developing in small caps; earlier this year FRTG acquired intellectual property rights from Intellimiedia Networks, Inc., for $5 million in cash and 20 million shares of FRTG. According to the 8k FRTG plans to raise $12 million by year end 2023. Essentially, Intellimedia turned over its assets and Intellectual Properties to Frontera, as Frontera has the platform in place to maximize the value of the purchased IP. Earlier this month FRTG reported it has commenced commercial sales and marketing efforts of Immersient, the intellectual property which was acquired from IntelliMedia Networks, Inc. and formerly sold under the Mixie brand name. Now sold and marketed under the Immersient brand, Frontera’s cloud media platform connects content producers, educational institutions, and event producers with participants and viewers, delivering immersive, personal experiences, interactive participation, existing device compatibility, familiar user conventions, and reliable, “always available” service. The stock is currently under heavy accumulation, with big momentum, a little float and some well-known investors jumping on board. We will be updating on FRTG when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with FRTG.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in FRTG either long or short and we have not been compensated for this article.
Recent Posts
Clean Vision Corp (OTC: CLNV): Overcoming the Plastic Waste Crisis
Meta Materials (NASDAQ: MMAT): More Due Diligence and Exploring Latest Developments
Integrated Cannabis Solutions’ (OTC: IGPK) 633% Surge: Exploring Catalysts, Company Overview, and Growth Potential in 2024
Sonoma Pharmaceuticals (NASDAQ: SNOA): Potential Surge to Speculations – What Lies Ahead?
1847 Holdings (NYSE: EFSH) Soars: Insights, Acquisitions, and What Lies Ahead
Trending
-
Uncategorized2 years ago
Meta Materials Inc (OTCMKTS: MMTLP) Enormous Short Position in Trouble as Next Bridge Hydrocarbons Set to Stop Trading (George Palikaras & John Brda on Corporate Action)
-
Micro Cap Insider3 years ago
Medium (KOK PLAY) The Parabolic Rise of Metal Arts (OTCMKTS: MTRT)
-
Media & Technology3 years ago
Healthier Choices Management Corp. (OTCMKTS: HCMC) Powerful Comeback Brewing as PMI Patent Infringement Lawsuit Moves Forward
-
Media & Technology4 years ago
AMECA Mining RM; the Rise of Southcorp Capital, Inc. (OTCMKTS: STHC)
-
Media & Technology3 years ago
SNPW (Sun Pacific Holding Corp) Power Brewing: 50MW solar farm project in Durango Mexico MOU with Atlas Medrecycler 48,000 SF New Partnership Queensland Australia Solar Farm.
-
BioPharma3 years ago
Asia Broadband (OTCMKTS: AABB) On the Move Northbound Since Sub $0.08 Dip as Crypto Innovator Elevates AABB Crypto Exchange & Enters the NFT Space
-
Uncategorized2 years ago
Meta Materials Inc (OTCMKTS: MMTLP) Short Squeeze S-1a4 Filing Signals S1 Approval Could Be Days Away (Next Bridge Hydrocarbons Spin-Off)
-
BioPharma3 years ago
Humbl Inc (OTCMKTS: HMBL) Major Reversal as Powerful Advisor Rejoins the Team & Looks to Uplist to Major Exchange